Drug-specific effects on mutant motility phenotypes | ARCADIA FyloGraph | FyloGraph

Fylo›ARCADIA›Graph

InferenceChain·arcadia

Drug-specific effects on mutant motility phenotypes

Reasoning explaining distinct and sometimes opposite responses of ida4 and cpc1-1 Chlamydomonas mutants to drug treatments, reflecting mutation-specific therapeutic potential.

Confidence

90%

◑partialactivecomplexity: mid

Reasoning Steps (3)

Mutation-specific drug responsivenessStep 1

Assay methodology explains phenotypic differencesStep 2

Linsitinib has opposing effects in ida4 and cpc1-1Step 3

Source

Study on drug treatments rescuing motility defects in Chlamydomonas mutants

Connections (6)

Torin2 rescues motility in ida4 cellsAssociation

Linsitinib worsens ida4 motilityAssociation

Ibudilast worsens ida4 motilityAssociation

Dynarrestin does not worsen ida4 motilityAssociation

TAK-063 recovers cpc1-1 motilityAssociation

Torin2 recovers cpc1-1 motilityAssociation